ELTP

Elite Pharmaceuticals, Inc.

ELTP·28659T200·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic

ELTP (Elite Pharmaceuticals, Inc.) is held by 0 institutional investors as of Q4 2023.

0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
ELTP

Smart Money Verdict

View all
Loading verdict
Held by 0 funds

Who's Trading

Source dates: Price Oct 16, 2026 · Insiders Oct 19, 2026 · Activists none · Congress none

InsiderDHDash Barry HBuy $26KOct 9, 2026
InsiderDHDash Barry HBuy $9KAug 19, 2026
InsiderPDPlassche DouglasExercise 2.5M shJan 9, 2026
Checking access…
View all insider trades

Top Holders

Checking access…
Action
Fisher Asset Management, LLCFisher Asset Management, LLC
Exited
0(-100.0%)$7,6930.0%+55.56%
0
ELTPELTPElite Pharmaceuticals, Inc.

Continue exploring

Smart money flow
Track where institutional capital is flowing
Discover new institutional entries
Fresh positions initiated this quarter
Check sector trends
Capital flows across GICS sectors

Other Healthcare stocks held by institutions

UNHUNHUNITEDHEALTH GROUP INC
417 holders · $300.5B
LLYLLYELI LILLY & CO
416 holders · $881.6B
TMOTMOTHERMO FISHER SCIENTIFIC INC
401 holders · $151.5B
JNJJNJJOHNSON & JOHNSON
398 holders · $415.6B
DHRDHRDANAHER CORP DEL
395 holders · $98.9B
ISRGISRGINTUITIVE SURGICAL INC
394 holders · $111.8B
MRKMRKMERCK & CO INC
391 holders · $230.3B
ABBVABBVABBVIE INC
386 holders · $303.9B
BSXBSXBOSTON SCIENTIFIC CORP
386 holders · $52.4B
ABTABTABBOTT LABORATORIES
383 holders · $114.2B
High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used